Oriva Therapeutics

About Oriva Therapeutics

Oriva Therapeutics is a clinical-stage women’s health biotechnology company focused on the development of first-in-class and best-in-class therapies for chronic, prevalent gynecological diseases with high unmet medical need. Based in Barcelona, the company has been created to advance innovative and disease-modifying approaches that aim to improve both clinical outcomes and quality of life for women. Oriva Therapeutics’ pipeline is built around two advanced programmes in endometriosis and uterine fibroids, leveraging novel chemistry targeting validated biological pathways and differentiated from existing treatment options. The company was seeded by Sabadell Asabys II, a fund managed by Asabys Partners, and is backed by assets originating from Oncostellae and Medibiofarma.